Neurologic manifestations of HIV infection

References

• Bacellar H, Munoz A, Miller EN, et al. Temporal trends in the incidence of HIV-l-related neurologic diseases: Multicenter AIDS Cohort Study, 1985–1992. Neurology 1994; 44(10):1892–900
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Update: trends in AIDS incidence—United States, 1996. MMWR 1997; 46(37):861–7
   PubMedGoogle Scholar
• Gonda MA, Wong-Staal F, Gallo RC, et al. Sequence homology and morphologic similarity of HTLV-III and visna virus, a pathogenic lentivirus. Science 1985; 227(4683):173–7
   PubMed Web of Science ®Google Scholar
• Price RW. Neurological complications of HIV infection. Lancet 1996; 348(9025):445–52
   Google Scholar
• Ho DD, Rota TR, Schooley RT, et al. Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome. N Engl J Med 1985; 313(24):1493–7
   PubMed Web of Science ®Google Scholar
• Gendelman HE, Persidsky Y, Ghorpade A, et al. The neuropathogenesis of the AIDS dementia complex. AIDS 1997; 11(Suppl A):35-45S
   Google Scholar
• Working Group of the American Academy of Neurology AIDS Task Force. Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV- 1) infection. Neurology 1991; 41(6):778–85
   Google Scholar
• McArthur JC, Hoover DR, Bacellar H, et al, for the Multicenter AIDS Cohort Study Group. Dementia in AIDS patients: incidence and risk factors. Neurology 1993; 43(11):2245–52
   PubMed Web of Science ®Google Scholar
• Price RW, Brew BJ. The AIDS dementia complex. J Infect Dis 1988; 158(5):1079–83
   PubMed Web of Science ®Google Scholar
• Brew BJ, Miller J. Human immunodeficiency virus type 1- related transient neurological deficits. Am J Med 1996; 101(3):257–61
   Google Scholar
• Navia BA, Jordan BD, Price RW. The AIDS dementia complex: I. Clinical features. Ann Neurol 1986; 19(6):517–24
   PubMed Web of Science ®Google Scholar
• Walot I, Miller BL, Chang L, et al. Neuroimaging findings in patients with AIDS. Clin Infect Dis 1996; 22(6):906–19
   Google Scholar
• Simpson DM, Tagliati M. Neurologic manifestations of HIV infection. Ann Intern Med 1994; 121(10):769–85 [Erratum, Ann Intern Med 1995;122(4):317]
   Google Scholar
• Brew BJ, Pemberton L, Cunningham P, et al. Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage. J Infect Dis 1997; 175(4):963–6
   Web of Science ®Google Scholar
• Gisslen M, Norkrans G, Svennerholm B, et al. The effect on human immunodeficiency virus type 1 RNA levels in cerebrospinal fluid after initiation of zidovudine or didanosine. J Infect Dis 1997; 175(2):434–7
   Google Scholar
• Portegies P, de Gans J, Lange JM, et al. Declining incidence of AIDS dementia complex after introduction of zidovudine treatment. BMJ 1989; 299(6703):819–21 [Erratum, BMJ 1989;299(6708):1141]
   Google Scholar
• Petito CK, Navia BA, Cho ES, et al. Vacuolar myelopathy pathologically resembling subacute combined degeneration in patients with the acquired immunodeficiency syndrome. N Engl J Med 1985; 312(14):874–9
   PubMed Web of Science ®Google Scholar
• Lipkin WI, Parry G, Kiprov D, et al. Inflammatory neuropathy in homosexual men with lymphadenopathy. Neurology 1985; 35(10):1479–83
   Google Scholar
• Cornblath DR, McArthur JC, Kennedy PG, et al. Inflammatory demyelinating peripheral neuropathies associated with human T-cell lymphotropic virus type III infection. Ann Neurol 1987; 21(1):32–40
   Google Scholar
• Freeman R, Roberts MS, Friedman LS, et al. Autonomic function and human immunodeficiency virus infection. Neurology 1990; 40(4):575–80
   Google Scholar
• Becker K, Gorlach I, Frieling T, et al. Characterization and natural course of cardiac autonomic nervous dysfunction in HIV- infected patients. AIDS 1997; 11(6):751–7
   Google Scholar
• Simpson DM, Citak KA, Godfrey E, et al. Myopathies associated with human immunodeficiency virus and zidovudine: can their effects be distinguished?Neurology 1993; 43(5):971–6
   Google Scholar
• Luft BJ, Hafner R, Korzun AH, et al, for the ACTG 077p/ ANRS 009 Study Team. Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome. N Engl J Med 1993; 329(14):995–1000
   PubMed Web of Science ®Google Scholar
• Vyas R, Ebright JR. Toxoplasmosis of the spinal cord in a patient with AIDS: case report and review. Clin Infect Dis 1996; 23(5):1061–5
   Google Scholar
• Centers for Disease Control and Prevention. 1997 USPHS/ IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. MMWR 1997; 46(RR-12):1–46
   Google Scholar
• Chuck SL, Sande MA. Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. N Engl J Med 1989; 321(12):794–9
   PubMed Web of Science ®Google Scholar
• Darras-Joly C, Chevret S, Wolff M, et al. Cryptococcus neoformans infection in France: epidemiologic features of and early prognostic parameters for 76 patients who were infected with human immunodeficiency virus. Clin Infect Dis 1996; 23(2):369–76
   Web of Science ®Google Scholar
• van der Horst CM, Saag MS, Cloud GA, et al, for the National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. N Engl J Med 1997; 337(1):15–21
   PubMed Web of Science ®Google Scholar
• Larsen RA, Bozzette SA, Jones BE, et al. Fluconazole combined with flucytosine for treatment of cryptococcal meningitis in patients with AIDS. Clin Infect Dis 1994; 19(4):741–5
   PubMed Web of Science ®Google Scholar
• Berger JR, Kaszovitz B, Post MJ, et al. Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection: a review of the literature with a report of sixteen cases. Ann Intern Med 1987; 107(1):78–87
   Web of Science ®Google Scholar
• Cinque P, Scarpellini P, Vago L, et al. Diagnosis of central nervous system complications in HIV-infected patients: cerebrospinal fluid analysis by the polymerase chain reaction. (Editorial) AIDS 1997; 11(1):1–17
   Google Scholar
• Power C, Nath A, Aoki FY, et al. Remission of progressive multifocal leukoencephalopathy following splenectomy and antiretroviral therapy in a patient with HIV infection. (Letter) N Engl J Med 1997; 336(9):661–2
   Google Scholar
• McCutchan JA. Cytomegalovirus infections of the nervous system in patients with AIDS. Clin Infect Dis 1995; 20(4):747–54
   PubMed Web of Science ®Google Scholar
• Arribas JR, Storch GA, Clifford DB, et al. Cytomegalovirus encephalitis. Ann Intern Med 1996; 125(7):577–87
   PubMed Web of Science ®Google Scholar
• Cohen BA. Prognosis and response to therapy of cytomegalovirus encephalitis and meningomyelitis in AIDS. Neurology 1996; 46(2):444–50
   Google Scholar
• Tramont EC. Syphilis in adults: from Christopher Columbus to Sir Alexander Fleming to AIDS. Clin Infect Dis 1995; 21(6):1361–9
   Google Scholar
• Berenguer J, Moreno S, Laguna F, et al. Tuberculous meningitis in patients infected with the human immunodeficiency virus. N Engl J Med 1992; 326(10):668–72
   Google Scholar
• Farrar DJ, Flanigan TP, Gordon NM, et al. Tuberculous brain abscess in a patient with HIV infection: case report and review. Am J Med 1997; 102(3):297–301
   Google Scholar
• Herndier BG, Kaplan LD, McGrath MS. Pathogenesis of AIDS lymphomas. AIDS 1994; 8(8):1025–49
   Google Scholar
• De Luca A, Antinori A, Cingolani A, et al. Evaluation of cerebrospinal fluid EBV-DNA and IL-10 as markers for in vivo diagnosis of AIDS-related primary central nervous system lymphoma. Br J Haematol 1995; 90(4):844–9 [Erratum, Br J Haematol 1995;91(4):1035]
   PubMed Web of Science ®Google Scholar